{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:05:09Z","timestamp":1790413509178,"version":"4.1.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL149452, R61\/R33 HL156152"],"award-info":[{"award-number":["R01 HL149452, R61\/R33 HL156152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular diseases (CVD) continue to be the leading cause of morbidity and mortality globally and claim the lives of over 17 million people annually. Current management of CVD includes risk factor modification and preventative strategies including dietary and lifestyle changes, smoking cessation, medical management of hypertension and cholesterol lipid levels, and even surgical revascularization procedures if needed. Although these strategies have shown therapeutic efficacy in reducing major adverse cardiovascular events such as heart attack, stroke, symptoms of chronic limb-threatening ischemia (CLTI), and major limb amputation significant compliance by patients and caregivers is required and off-target effects from systemic medications can still result in organ dysfunction. Stem cell therapy holds major potential for CVD applications but is limited by the low quantities of cells that are able to traffic to and engraft at diseased tissue sites. New preclinical investigations have been undertaken to modify mesenchymal stem cells (MSCs) to achieve targeted cell delivery after systemic administration. Although previous reviews have focused broadly on the modification of MSCs for numerous local or intracoronary administration strategies, here we review recent preclinical advances related to overcoming challenges imposed by the high velocity and dynamic flow of the circulatory system to specifically deliver MSCs to ischemic cardiac and peripheral tissue sites. Many of these technologies can also be applied for the targeted delivery of other types of therapeutic cells for treating various diseases.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1236345","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T09:46:22Z","timestamp":1691142382000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements"],"prefix":"10.3389","volume":"10","author":[{"given":"Carlos Theodore","family":"Huerta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca A.","family":"Voza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulexi Y.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omaida C.","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"732742","DOI":"10.1155\/2013\/732742","article-title":"MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation","volume":"2013","author":"Kean","year":"2013","journal-title":"Stem Cells Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3727\/096368912X636948","article-title":"No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia","volume":"21","author":"Klepanec","year":"2012","journal-title":"Cell Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1524-475X.2010.00616.x","article-title":"Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood","volume":"18","author":"Luo","year":"2010","journal-title":"Wound Repair Regen"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","article-title":"Challenges and advances in clinical applications of mesenchymal stromal cells","volume":"14","author":"Zhou","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0154053","DOI":"10.1371\/journal.pone.0154053","article-title":"Directing and potentiating stem cell-mediated angiogenesis and tissue repair by cell surface E-selectin coating","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.ymthe.2018.08.011","article-title":"PDGF Restores the defective phenotype of adipose-derived mesenchymal stromal cells from diabetic patients","volume":"26","author":"Capilla-Gonz\u00e1lez","year":"2018","journal-title":"Mol Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/wound.2022.0107","article-title":"Methods and limitations of augmenting mesenchymal stem cells for therapeutic applications","volume":"12","author":"Huerta","year":"2023","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jmbbm.2012.02.018","article-title":"Stiffening of human mesenchymal stem cell spheroid microenvironments induced by incorporation of gelatin microparticles","volume":"11","author":"Baraniak","year":"2012","journal-title":"J Mech Behav Biomed Mater"},{"key":"B9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/stem.2751","article-title":"Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies","volume":"36","author":"Qadura","year":"2018","journal-title":"Stem Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1113982","DOI":"10.3389\/fcvm.2023.1113982","article-title":"Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: a review of preclinical and clinical studies","volume":"10","author":"Huerta","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1186\/ar576","article-title":"Endothelial activation: intracellular signaling pathways","volume":"4","author":"Pober","year":"2002","journal-title":"Arthritis Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1600-065X.2007.00533.x","article-title":"Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium","volume":"218","author":"Vestweber","year":"2007","journal-title":"Immunol Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e78885","DOI":"10.1371\/journal.pone.0078885","article-title":"Identification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues","volume":"8","author":"Mesri","year":"2013","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e46996","DOI":"10.1371\/journal.pone.0046996","article-title":"Characterization of a distinct population of circulating human non-adherent endothelial forming cells and their recruitment via intercellular adhesion molecule-3","volume":"7","author":"Appleby","year":"2012","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e91808","DOI":"10.1371\/journal.pone.0091808","article-title":"Adhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferation","volume":"9","author":"Sievert","year":"2014","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e200022","DOI":"10.1212\/NXI.0000000000200022","article-title":"CLMP Promotes leukocyte migration across brain barriers in multiple sclerosis","volume":"9","author":"Fournier","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.3390\/ijms232012397","article-title":"Current nanomedicine for targeted vascular disease treatment: trends and perspectives","volume":"23","author":"Choi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.0022-202X.2004.09301.x","article-title":"The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing","volume":"9","author":"Sackstein","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/glycob\/cww026","article-title":"Fulfilling Koch\u2019s postulates in glycoscience: HCELL, GPS and translational glycobiology","volume":"26","author":"Sackstein","year":"2016","journal-title":"Glycobiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/SLA.0b013e3181f5a079","article-title":"Identification of E-selectin as a novel target for the regulation of post-natal neovascularization: implications for diabetic wound healing","volume":"252","author":"Liu","year":"2010","journal-title":"Ann Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"34416","DOI":"10.1038\/srep34416","article-title":"SDF-1\u03b1-induced dual pairs of E-selectin\/ligand mediate endothelial progenitor cell homing to critical ischemia","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1803567","DOI":"10.1002\/adfm.201803567","article-title":"Platelet-inspired nanocells for targeted heart repair after ischemia\/reperfusion injury","volume":"29","author":"Su","year":"2019","journal-title":"Adv Funct Mater"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/acs.accounts.9b00137","article-title":"Chemical engineering of cell therapy for heart diseases","volume":"52","author":"Li","year":"2019","journal-title":"Acc Chem Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10840-014-9940-9","article-title":"Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel","volume":"41","author":"Panda","year":"2014","journal-title":"J Interv Card Electrophysiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1021\/acsabm.0c01473","article-title":"Polymer cell surface coating enhances mesenchymal stem cell retention and cardiac protection","volume":"4","author":"Peng","year":"2021","journal-title":"ACS Appl Bio Mater"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3727\/096368911X627381","article-title":"Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia\/reperfusion","volume":"21","author":"Cheng","year":"2012","journal-title":"Cell Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3727\/096368914X685302","article-title":"Comparison of magnetic intensities for mesenchymal stem cell targeting therapy on ischemic myocardial repair: high magnetic intensity improves cell retention but has no additional functional benefit","volume":"24","author":"Shen","year":"2015","journal-title":"Cell Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"310928","DOI":"10.4061\/2011\/310928","article-title":"Stem cells for cardiac repair: status, mechanisms, and new strategies","volume":"2011","author":"Mingliang","year":"2011","journal-title":"Stem Cells Int"},{"key":"B29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ijcard.2015.08.117","article-title":"Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium","volume":"201","author":"Suresh","year":"2015","journal-title":"Int J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"826687","DOI":"10.3389\/fcvm.2021.826687","article-title":"E-selectin-overexpressing mesenchymal stem cell therapy confers improved reperfusion, repair, and regeneration in a murine critical limb ischemia model","volume":"8","author":"Quiroz","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1084\/jem.20170689","article-title":"The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes","volume":"214","author":"Anzai","year":"2017","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.7150\/thno.81336","article-title":"CSF2RB overexpression promotes the protective effects of mesenchymal stromal cells against ischemic heart injury","volume":"13","author":"Qi","year":"2023","journal-title":"Theranostics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ymthe.2019.03.010","article-title":"A novel endogenous damage signal, CSF-2, activates multiple beneficial functions of adipose tissue-derived mesenchymal stem cells","volume":"27","author":"Park","year":"2019","journal-title":"Mol Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13287-022-02922-z","article-title":"Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection","volume":"13","author":"Huang","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ymthe.2020.06.026","article-title":"Adiponectin stimulates exosome release to enhance mesenchymal stem-cell-driven therapy of heart failure in mice","volume":"28","author":"Nakamura","year":"2020","journal-title":"Mol Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1161\/CIRCRESAHA.119.315806","article-title":"N-cadherin overexpression mobilizes the protective effects of mesenchymal stromal cells against ischemic heart injury through a \u03b2-catenin\u2013dependent manner","volume":"126","author":"Yan","year":"2020","journal-title":"Circ Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1703","article-title":"Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone","volume":"14","author":"Sackstein","year":"2008","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005949","article-title":"Novel gene-modified mesenchymal stem cell therapy reverses impaired wound healing in ischemic limbs","author":"Huerta","year":"2023","journal-title":"Ann Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1124\/jpet.119.259796","article-title":"Engineered mesenchymal stem cells for targeting solid tumors: therapeutic potential beyond regenerative therapy","volume":"370","author":"Cheng","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"143780","DOI":"10.1172\/JCI143780","article-title":"Overcoming innate immune barriers that impede AAV gene therapy vectors","volume":"131","author":"Muhuri","year":"2021","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"E8999","DOI":"10.3390\/ijms21238999","article-title":"Current status of cell-based therapy in patients with critical limb ischemia","volume":"21","author":"Jaluvka","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"E3446","DOI":"10.3390\/ijms20143446","article-title":"Autologous cellular method using micrografts of human adipose tissue derived follicle stem cells in androgenic alopecia","volume":"20","author":"Gentile","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1253\/circj.cj-11-1135","article-title":"Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study","volume":"76","author":"Lee","year":"2012","journal-title":"Circ J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1903516","DOI":"10.1002\/advs.201903516","article-title":"Targeted repair of vascular injury by adipose-derived stem cells modified with P-selectin binding peptide","volume":"7","author":"Yan","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41551-017-0182-x","article-title":"Targeted repair of heart injury by stem cells fused with platelet nanovesicles","volume":"2","author":"Tang","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"B47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fbioe.2017.00032","article-title":"Soluble factors on stage to direct mesenchymal stem cells fate","volume":"5","author":"Sobacchi","year":"2017","journal-title":"Front Bioeng Biotechnol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/sctm.16-0485","article-title":"Safety profile of good manufacturing practice manufactured interferon \u03b3-primed mesenchymal stem\/stromal cells for clinical trials","volume":"6","author":"Guess","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/scd.2016.0209","article-title":"Priming equine bone marrow-derived mesenchymal stem cells with proinflammatory cytokines: implications in immunomodulation-immunogenicity balance, cell viability, and differentiation potential","volume":"26","author":"Barrachina","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1161\/CIRCRESAHA.109.196030","article-title":"Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment and capillary density in the injured myocardium","volume":"106","author":"Huang","year":"2010","journal-title":"Circ Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12889-021-10429-0","article-title":"Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017","volume":"21","author":"Amini","year":"2021","journal-title":"BMC Public Health"},{"key":"B53","year":""},{"key":"B54","doi-asserted-by":"publisher","first-page":"2048004016687211","DOI":"10.1177\/2048004016687211","article-title":"Primary prevention of cardiovascular disease: a review of contemporary guidance and literature","volume":"6","author":"Stewart","year":"2017","journal-title":"JRSM Cardiovasc Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.avsg.2020.01.019","article-title":"Direct retrograde bypass is preferable to antegrade bypass for open mesenteric revascularization","volume":"66","author":"Huerta","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13287-022-02852-w","article-title":"Epigenetic therapy targeting bone marrow mesenchymal stem cells for age-related bone diseases","volume":"13","author":"Zhao","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B57","doi-asserted-by":"publisher","first-page":"024","DOI":"10.24966\/srdt-2060\/100024","article-title":"Increasing the therapeutic potential of stem cell therapies for critical limb ischemia","volume":"6","author":"Quiroz","year":"2020","journal-title":"HSOA J Stem Cells Res Dev Ther"},{"key":"B58","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/14653240802129893","article-title":"Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction","volume":"10","author":"Du","year":"2008","journal-title":"Cytotherapy"},{"key":"B59","doi-asserted-by":"publisher","first-page":"929466","DOI":"10.3389\/fcvm.2022.929466","article-title":"E-Selectin\/AAV2\/2 gene therapy alters angiogenesis and inflammatory gene profiles in mouse gangrene model","volume":"9","author":"Ribieras","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e6679390","DOI":"10.1155\/2023\/6679390","article-title":"E-selectin\/AAV gene therapy promotes myogenesis and skeletal muscle recovery in a mouse hindlimb ischemia model","volume":"2023","author":"Ribieras","year":"2023","journal-title":"Cardiovasc Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1657","DOI":"10.1002\/wnan.1657","article-title":"Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors","volume":"13","author":"Dobrovolskaia","year":"2021","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/hr.2015.134","article-title":"Current therapies and investigational drugs for peripheral arterial disease","volume":"39","author":"Suzuki","year":"2016","journal-title":"Hypertens Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.3390\/ijms24054396","article-title":"Induction of angiogenesis by genetically modified human umbilical cord blood mononuclear cells","volume":"24","author":"Gatina","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1236345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T09:46:28Z","timestamp":1691142388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1236345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":63,"alternative-id":["10.3389\/fcvm.2023.1236345"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1236345","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"article-number":"1236345"}}